Tokyo medical cooperation notebook (cancer community cooperation critical path)

In the Tokyo metropolitan area, medical institutions in the Tokyo area are jointly used in cooperation with the cancer treatment cooperation core hospitals, the Tokyo cancer treatment cooperation base hospitals, the Tokyo cancer treatment cooperation hospitals, the National Cancer Center Hospital, and the Tokyo Medical Association. 5 major cancers (lung cancer, stomach cancer, liver cancer, colorectal cancer, breast cancer) and prostate cancer regional collaboration critical path "Tokyo medical cooperation notebook" that can be used for.
The "Tokyo Medical Cooperation Notebook" is a subcommittee for each type of cancer (lung cancer, stomach cancer, liver cancer, colorectal cancer, breast cancer, prostate cancer) in the Tokyo Cancer Treatment Cooperation Council / Critical Path Subcommittee. Installed and created. The current subcommittee consists of national base hospitals, metropolitan base hospitals, partner hospitals, the National Cancer Center Hospital, and the Tokyo Medical Association.

It is used by cancer patients after undergoing specialized treatment such as surgery, and is a notebook that summarizes the patient's medical treatment plan for 5 to 10 years ahead. .

• By bringing this notebook when a patient visits a medical institution, etc., doctors at specialized hospitals, family doctors, and other medical institutions can share the patient's treatment progress, enabling more appropriate medical care. Become.
• By having a notebook, the patient can know "when", "where", and "what kind" of medical examinations and examinations.

Use of notebook

The attending physician at the hospital where the surgery or other treatment was performed examines whether the medical collaboration is appropriate for the patient's medical care, and after fully explaining to the patient and family and obtaining their consent, begins using the notebook. increase.

After starting to use the notebook

Your family doctor will administer your daily medical examination and medication when your symptoms have subsided. You will be asked to visit the hospital where you received treatment such as surgery at a milestone.
If you have any concerns, please consult your family doctor. If it is an emergency and you cannot see your family doctor because it is a holiday or at night, please contact the hospital where you received surgery or other treatment. (The phone number is listed in the notebook.)

others

If you have any questions or concerns, please consult your doctor, nurse, or the medical consultation room of each hospital.

The Tokyo Medical Cooperation Notebook was revised in July 2020.

In addition to being on the critical path for prostate cancer community collaboration, it is intended for those who are suspected of having prostate cancer and have been diagnosed as cancer-free after a thorough examination.

The Tokyo PSA notebook was revised in July 2020.

The collaboration promotion committee of the Tokyo Metropolitan Council for Cancer Care Collaboration, Critical Path Subcommittee, has created a procedure manual for operation in order to facilitate common use of the Tokyo Metropolitan Medical Collaboration Handbook. For the five major cancers, prostate cancer, and PSA, there are separate versions for treatment hospitals (planning hospitals), patients, and primary care physicians (collaborating medical institutions).

In the operation of the Tokyo Medical Cooperation Notebook, cancer treatment cooperation base hospitals (hospitals that formulate plans) will receive a "cancer treatment cooperation planning fee", and clinics (collaborating medical institutions) will receive a "cancer treatment cooperation guidance fee". ” can be calculated.
In calculating the medical fee, it is necessary to notify the Kanto-Shinetsu Bureau of Health and Welfare in advance of the facility standards.
Regarding this notification, since April 2012, when the planning hospital submits the facility standards for the "cancer treatment cooperation plan formulation fee", It is now possible to submit such notifications together.
In Tokyo, there is a demand for a system that allows as many medical institutions as possible to collaborate, such as the trend of patients receiving treatment beyond the secondary medical area. We are creating a comprehensive list of institutions.
This comprehensive list is created by the Tokyo Medical Association as a coordinator, and with this list, cancer treatment cooperation base hospitals (hospitals that formulate plans) submit notifications to the Kanto Shinetsu Bureau of Health and Welfare.

The planning hospitals to report are as follows.

A list of contact information (departments in charge, etc.) at hospitals planning for the use of the Tokyo Medical Cooperation Notebook is provided.

The following three documents are required for notification of facility standards for “cancer treatment cooperation planning fee/cancer treatment cooperation guidance fee”.